Casdin Private Growth Equity Fund II GP, LLC is Director & 10% Owner at STANDARD BIOTOOLS INC. (LAB). They have made 1 open-market trade across 1 company since 2024, most recently 2024-03-05.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $646K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LAB | 11,497,928 | $8.3M |
Shares reported on the most recent Form 4, priced at the 2024-03-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LAB | BUY | 2024-03-04 | 2024-03-06 | $2.57 | $646K | -3.7% | +1.9% | -5.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.